Bristol-Myers Bears Brunt Of Costs In Eliquis Patent Fight
The Irish Court of Appeal has ordered Bristol-Myers Squibb to shoulder the majority of the legal costs for a significant patent infringement appeal over its blood thinner Eliquis, the company's biggest...To view the full article, register now.
Already a subscriber? Click here to view full article